Peripheral Nerve Stimulators Market - Top Companies and Manufacturers

Companies Dominating the Peripheral Nerve Stimulators Landscape

Key companies in the peripheral nerve stimulators market are driving innovation through advancements in technology, such as wireless, implantable, and programmable devices that enhance patient comfort and treatment efficacy. For instance, in June 2024, Nalu Medical announced key findings from a clinical trial evaluating the Nalu peripheral nerve stimulation system for treating chronic pain. Companies are developing compact, cost-effective PNS solutions with improved customization, integrating AI and remote monitoring to make therapy more accessible and personalized for chronic pain patients. These key players include:

Braun SE
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Boston Scientific Corporation
Curonix LLC
SPR Therapeutics
AVNS
Teleflex Incorporated
SUNMED
Xavant Technology (Pty) Ltd
Neuspera Medical
Vygon
Medtronic

Browse Key Market Insights with Data Illustration:

Peripheral Nerve Stimulators Market Size, Growth Forecasts 2037

In the News

In April 2023, Neuspera Medical received FDA clearance for its next-generation ultra-miniaturized neurostimulation system, featuring a micro-implant, wireless wearable transmitter, and iPad-based clinician programmer for chronic illness treatment.
In January 2022, Medtronic announced FDA approval for its Intellis rechargeable and Vanta recharge-free neurostimulators to treat chronic pain associated with diabetic peripheral neuropathy (DPN).

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the peripheral nerve stimulators market was over USD 541.2 million.

The market size for the peripheral nerve stimulators market is projected to reach USD 1.28 billion by the end of 2037 expanding at a CAGR of 7.5% during the forecast period i.e., between 2025-2037.

The major players in the market are SPR Therapeutics, AVNS, Teleflex Incorporated, and others.

In terms of product type segment, the transcutaneous segment is anticipated to garner the largest market share by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 39.2% by the end of 2037 and provide more business opportunities in the future.

Peripheral Nerve Stimulators Market - Top Companies and Manufacturers

Companies Dominating the Peripheral Nerve Stimulators Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the peripheral nerve stimulators market?

What is the outlook for the peripheral nerve stimulators market?

Who are the major players dominating the peripheral nerve stimulators market?

Which application segment will capture the significant market share for the peripheral market by 2037?

Which region will provide more business opportunities for the growth of the peripheral nerve stimulators market in the future?